Rapid, Safe and Effective Vaccines for Global Health

8/14/21 – VIC Technology Venture Development, LLC (VIC), announced today the formation of Colorado-based Solaris Vaccines, Inc., to advance a new vaccine development platform that can be used with coronavirus and other pathogens capable of causing pandemics. >>Read More

3/22/21 – Researchers at Colorado State University are working on four COVID-19 vaccine candidates, one of which is nearing human clinical trials >>Read More

2/22/21 – As scientists at Colorado State University continue their research on four coronavirus vaccine candidates, investigators are developing a plan to collaborate with scientists at other universities to create a pan-coronavirus vaccine that could help in future pandemics. >>Read More

9/20/20 – A team of scientists at Colorado State University was awarded a base contract worth $3.1 million from the National Institutes of Health to continue development of a coronavirus vaccine candidate known as SolaVAX™. >>Read More

6/25/20 – A team of infectious disease researchers at Colorado State University has entered into an agreement with the Biomedical Advanced Research and Development Authority (BARDA) to further develop a novel virus inactivation process, successfully used for MERS, which has the potential to inactivate the SARS-CoV-2 virus.>>Read More

4/15/20 – We are both biotechnology researchers and are currently seeking to repurpose an existing medical manufacturing platform to quickly develop a vaccine candidate for COVID-19.>>Read More